Mitchell Evers Selected Research

Communicable Diseases (Infectious Diseases)

9/2023

Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitchell Evers Research Topics

Disease

9	Neoplasms (Cancer) 03/2024 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2023 - 10/2021
2	Neuroblastoma 01/2023 - 10/2021
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Lymphoma (Lymphomas) 10/2021
1	Pain (Aches) 10/2021
1	Hypersensitivity (Allergy) 12/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018

Drug/Important Bio-Agent (IBA)

7	Immunoglobulin G (IgG)IBA 03/2024 - 01/2019
7	AntibodiesIBA 01/2023 - 01/2019
6	Immunoglobulin A (IgA)IBA 09/2023 - 01/2019
4	Monoclonal AntibodiesIBA 10/2021 - 01/2018
3	Complement System Proteins (Complement)IBA 03/2024 - 01/2019
2	Fc(alpha) receptorIBA 09/2023 - 01/2023
2	dinutuximabIBA 01/2023 - 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	CaspasesIBA 10/2021
1	Rituximab (Mabthera)FDA Link 12/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	necitumumabIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2019
2	Immunotherapy 09/2023 - 01/2023